Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06023667 · ClinicalTrials.gov registry record · NA

SMART-IBD App Trial

A NA study of Ulcerative Colitis and Crohn Disease, sponsored by Children's Hospital Medical Center, Cincinnati.

Completed
Registry status
NA
Development phase
45
Enrollment target
1
Study location

NCT06023667 is a NA study of Ulcerative Colitis and Crohn Disease that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 45 participants, below the 2,057-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06023667, a NA study of Ulcerative Colitis and Crohn Disease, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.

COMPLETED
Registry status
NA
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

The objective of this trial is to test whether a smartphone app, SMART-IBD, is effective in improving medication adherence and self-management skills in adolescents with IBD. The investigators will conduct a randomized control trial to compare a sample of 20 youth (ages 13-17) with IBD using an app that has educational content and medication reminders to 20 youth in an attention control group. The length of the intervention will include one month of baseline adherence data collection, one month of intervention, and one month of post-treatment adherence data collection.

Interventions

  • BEHAVIORAL SMART-IBD

Study Locations (1)

Ohio

  • Cincinnati Children's Hospital Medical Center - Cincinnati

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2022-12-14
Est. Completion 2023-12-28
Phase NA

What the Registry Record Tells You About NCT06023667

The ClinicalTrials.gov registry entry for NCT06023667 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,057-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (98% lower). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Ulcerative Colitis appearing as the primary indexed condition, and to 1 intervention - of which SMART-IBD is the first listed.

NCT06023667 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT06023667 about?

NCT06023667 is a clinical study titled "SMART-IBD App Trial". The objective of this trial is to test whether a smartphone app, SMART-IBD, is effective in improving medication adherence and self-management skills in adolescents with IBD. The investigators will conduct a randomized control trial to compare a sample of 20 youth (ages 13-17) with IBD using an app ...

What is the current status of trial NCT06023667?

This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2022-12-14. Estimated completion is 2023-12-28.

What conditions does trial NCT06023667 study?

This clinical trial studies the following conditions: Ulcerative Colitis, Crohn Disease, Inflammatory Bowel Diseases, IBD.

What interventions are being tested in trial NCT06023667?

The interventions under investigation include: SMART-IBD (BEHAVIORAL).

Who is sponsoring clinical trial NCT06023667?

This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06023667 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ulcerative Colitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.